MARC

Tag First Indicator Second Indicator Subfields
LEADER 00000cam a2200000 i 4500
001 in00005505621
006 m o d
007 cr un|||||||||
008 120614s2012 dcua ob 001 0 eng d
005 20241009195844.3
035 |a (OCoLC)ocn795533660 
040 |a UIU  |b eng  |e pn  |c UIU  |d ACY  |d UIU  |d OCLCQ  |d OHS  |d OCLCF  |d ZWZ  |d OCLCQ  |d OCLCO  |d ACY  |d TMC  |d LIP  |d MERER  |d OCLCO  |d OCLCQ  |d NJR  |d OCLCO  |d OCLCQ  |d OCLCA  |d AU@  |d OCLCO  |d WYU  |d CASSC  |d OCLCO  |d OCLCA  |d CUY  |d LEAUB  |d U3G  |d OCLCO  |d EBLCP  |d YDX  |d OCLCQ  |d UKBTH  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCA  |d OCLCO  |d N$T  |d OCLCO  |d OCLCQ  |d OCLCO  |d UIU  |d OCLCL  |d OCLCQ 
066 |c (S 
019 |a 836013152  |a 990522071  |a 1058078994 
020 |a 9780841227668  |q (electronic bk.) 
020 |a 0841227667  |q (electronic bk.) 
020 |z 9780841227651  |q (alk. paper) 
020 |z 0841227659  |q (alk. paper) 
035 |a (OCoLC)795533660  |z (OCoLC)836013152  |z (OCoLC)990522071  |z (OCoLC)1058078994 
050 4 |a RS420  |b .G59 2012 
060 4 |a QV 745 
072 7 |a MED  |x 071000  |2 bisacsh 
082 0 4 |a 615.1/9  |2 23 
084 |a MED071000  |2 bisacsh 
049 |a TXAM 
245 0 0 |a Glycobiology and drug design /  |c Anatole A. Klyosov, editor ; sponsored by the ACS Division of Carbohydrate Chemistry. 
264 1 |a Washington DC :  |b American Chemical Society,  |c ©2012. 
300 |a 1 online resource :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a ACS symposium series ;  |v 1102 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
546 |a English. 
650 0 |a Drugs  |x Design. 
650 0 |a Glycomics. 
650 0 |a Drug development. 
650 0 |a Carbohydrate drugs. 
650 2 |a Drug Design 
650 2 |a Glycomics 
650 4 |a Health & Biological Sciences. 
650 4 |a Pharmacy, Therapeutics, & Pharmacology. 
650 6 |a Médicaments  |x Conception. 
650 6 |a Glycomique. 
650 6 |a Médicaments  |x Développement. 
650 6 |a Médicaments à base de glucides. 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a Carbohydrate drugs  |2 fast 
650 7 |a Drug development  |2 fast 
650 7 |a Drugs  |x Design  |2 fast 
650 7 |a Glycomics  |2 fast 
655 7 |a Electronic books.  |2 local 
700 1 |a Klesov, A. A.  |q (Anatoliĭ Alekseevich)  |1 https://id.oclc.org/worldcat/entity/E39PBJwhCCk8hRHRCxqPCgdhHC 
710 2 |a American Chemical Society.  |b Division of Carbohydrate Chemistry. 
758 |i has work:  |a Glycobiology and drug design (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGCtTyBKy7tMbC73ByGDmb  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Glycobiology and drug design.  |d Washington DC : American Chemical Society, ©2012  |z 9780841227651  |w (DLC) 2012012730  |w (OCoLC)794922700 
830 0 |a ACS symposium series ;  |v 1102. 
856 4 0 |u http://proxy.library.tamu.edu/login?url=https://pubs.acs.org/doi/book/10.1021/bk-2012-1102  |z Connect to the full text of this electronic book  |t 0 
880 0 0 |6 505-00/(S  |t Carbohydrates and Drug Design /  |r Klyosov, Anatole A. --  |t Galectin-Targeted Drug Design /  |r Klyosov, Anatole A. --  |t Development of a Galactomannan Polysaccharide as a Vehicle To Improve the Efficacy of Chemotherapeutics /  |r Zomer, Eliezer, Galectin Therapeutics, 7 Well Avenue, Newton, MA 02459; Klyosov, Anatole A., Galectin Therapeutics, 7 Well Avenue, Newton, MA 02459; Platt, David, Pro-Pharmaceuticals, 7 Well Avenue, Newton, MA 02459 --  |t DAVANAT® (GM-CT-01) and Colon Cancer: Preclinical and Clinical (Phase I and II) Studies /  |r Klyosov, Anatole, Galectin Therapeutics, 7 Well Avenue, Newton, MA 02459; Zomer, Eliezer, Galectin Therapeutics, 7 Well Avenue, Newton, MA 02459; Platt, David, Pro-Pharmaceuticals, 7 Well Avenue, Newton, MA 02459 --  |t Synthesis and Biological Activity of Galactomycin and DoxoDavanat, New Conjugates of Doxorubicin with D-Galactose and 1,4-β-D-Galactomannan /  |r Tevyashova, Anna N., Gause Institute of New Antibiotics, Russian Academy of Medical Sciences, Moscow 119021, Russia; Klyosov, Anatole A., Galectin Therapeutics Inc., 7 Well Avenue, Newton, MA 02459; Olsufyeva, Eugenia N., Gause Institute of New Antibiotics, Russian Academy of Medical Sciences, Moscow 119021, Russia; Preobrazhenskaya, Maria N., Gause Institute of New Antibiotics, Russian Academy of Medical Sciences, Moscow 119021, Russia; Zomer, Eliezer, Galectin Therapeutics Inc., 7 Well Avenue, Newton, MA 02459 --  |t Carbohydrate-Based Vaccines against HIV/AIDS /  |r Wang, Lai-Xi--  |t Toward a Carbohydrate-Based HIV-1 Vaccine /  |r Kong, Leopold, Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037; Julien, Jean-Philippe, Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037; Calarese, Daniel, Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037; Scanlan, Christopher, Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, The Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, United Kingdom; Lee, Hing-Ken, Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037; Rudd, Pauline, The Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, United Kingdom; Wong, Chi-Huey, Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA, 92037; Dwek, Raymond A., The Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, United Kingdom; Burton, Dennis R., Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037; Wilson, Ian A., Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA, 92037 --  |t Cationic Polysaccharides in the Treatment of Pathogenic Candida Infections /  |r Mazar Ben-Josef, Avital; Platt, David; Zomer, Eliezer --  |t Synthetic Methods To Incorporate α-Linked 2-Amino-2-Deoxy-D-Glucopyranoside and 2-Amino-2-Deoxy-D-Galactopyranoside Residues into Glycoconjugate Structures /  |r Kerns, Robert J.; Wei, Peng --  |t Systematic Synthesis of Aminosugars and Their Stereoselective Glycosylation /  |r Wang, Jinhua; Chang, Cheng-Wei Tom --  |t Practical Applications of Computational Studies of the Glycosylation Reaction /  |r Whitfield, Dennis M., Institute for Biological Sciences, National Research Council Canada, 100 Sussex Dr., Ottawa, Ontario, Canada K1A 0R6; Nukada, Tomoo, The Institute for Physical and Chemical Research (RIKEN), Wako-shi, 351-01 Saitama, Japan --  |t Editor's Biography 
955 |a ASC eBooks Complete Collection 
994 |a 92  |b TXA 
999 f f |s e09dd139-6961-4310-adc4-b813dbfa727c  |i 6a2ec782-1f75-4906-b479-989d299958d5  |t 0 
952 f f |a Texas A&M University  |b College Station  |c Electronic Resources  |d Available Online  |t 0  |e RS420 .G59 2012  |h Library of Congress classification 
998 f f |a RS420 .G59 2012  |t 0  |l Available Online